NEW YORK (GenomeWeb News) – Zygem and Rubicon Genomics have struck an agreement that will incorporate Zygem's enzymatic nucleic acid extraction technology with Rubicon's pre-analytical platform in an offering aimed at DNA and RNA analysis, Zygem said today.

The integration initially will focus on diagnostic single-cell whole genome amplification kits, but it could expand to include other research and diagnostic products, Zygem said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.